div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020P. Tandon, A. J. Montano-Loza (eds.)Frailty and Sarcopenia in Cirrhosishttps://doi.org/10.1007/978-3-030-26226-6_18 18. A Research Wish List to Understand, Diagnose, and Manage Frailty and Sarcopenia Michael A. Dunn1, 2 (1)…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020P. Tandon, A. J. Montano-Loza (eds.)Frailty and Sarcopenia in Cirrhosishttps://doi.org/10.1007/978-3-030-26226-6_15 15. Upcoming Pharmacological and Interventional Therapies for the Treatment of Physical Frailty and Sarcopenia Penelope Hey1, 2 and…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020P. Tandon, A. J. Montano-Loza (eds.)Frailty and Sarcopenia in Cirrhosishttps://doi.org/10.1007/978-3-030-26226-6_10 10. The Role of Changes in Subcutaneous and Visceral Adiposity, Sarcopenic Obesity, and Myosteatosis/Muscle Quality in…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020P. Tandon, A. J. Montano-Loza (eds.)Frailty and Sarcopenia in Cirrhosishttps://doi.org/10.1007/978-3-030-26226-6_16 16. Should Frailty Include Multidimensional and Dynamic Factors? Darryl B. Rolfson1 (1) Division of Geriatric Medicine, Department of…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020P. Tandon, A. J. Montano-Loza (eds.)Frailty and Sarcopenia in Cirrhosishttps://doi.org/10.1007/978-3-030-26226-6_8 8. Sex-, Age-, and Ethnicity-Dependent Variation in Body Composition: Can There Be a Single Cutoff? Maria Cristina Gonzalez1 , Jingjie Xiao2, 3, 4 …
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020P. Tandon, A. J. Montano-Loza (eds.)Frailty and Sarcopenia in Cirrhosishttps://doi.org/10.1007/978-3-030-26226-6_2 2. The Definition and Diagnosis of Frailty in the Research and Clinical Settings Hui-Wei Chen1 and Andres Duarte-Rojo1, 2 …
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020P. Tandon, A. J. Montano-Loza (eds.)Frailty and Sarcopenia in Cirrhosishttps://doi.org/10.1007/978-3-030-26226-6_13 13. Physical Frailty and Sarcopenia in End-Stage Liver Disease: Do They Improve After Liver Transplantation? Rahima A. Bhanji1 …
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020P. Tandon, A. J. Montano-Loza (eds.)Frailty and Sarcopenia in Cirrhosishttps://doi.org/10.1007/978-3-030-26226-6_1 1. Definition and Diagnosis of Sarcopenia in the Research and Clinical Settings Aldo J. Montano-Loza1 and Maryam Ebadi1 (1) Department…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020P. Tandon, A. J. Montano-Loza (eds.)Frailty and Sarcopenia in Cirrhosishttps://doi.org/10.1007/978-3-030-26226-6_12 12. Frailty and Sarcopenia in the Selection of Candidates for Liver Transplantation Christopher J. Sonnenday1 (1) Department of Surgery,…
div class=”ChapterContextInformation”> © Springer Nature Switzerland AG 2020P. Tandon, A. J. Montano-Loza (eds.)Frailty and Sarcopenia in Cirrhosishttps://doi.org/10.1007/978-3-030-26226-6_11 11. Evidence for the Assessment of Physical Frailty and Sarcopenia in Hospitalized Patients and the Role of Assessing…
